Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -393.85%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-404.74%
RETURN ON EQUITY (ROE) AVG 3Y
-329.53%
RETURN ON EQUITY (ROE) AVG 5Y
-239.41%
RETURN ON EQUITY (ROE) AVG 10Y
-95.84%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tempest Therapeutics, Inc.
Market Cap
$12.58M
Return on Equity (ROE)
N/A
TTM Avg
-404.74%
3Y Avg
-329.53%
5Y Avg
-239.41%
Market Cap
$12.48M
Return on Equity (ROE)
N/A
TTM Avg
-201.97%
3Y Avg
-21.23%
5Y Avg
365.72%
Market Cap
$12.44M
Return on Equity (ROE)
N/A
TTM Avg
-162.71%
3Y Avg
-135.96%
5Y Avg
-98.83%
Market Cap
$12.78M
Return on Equity (ROE)
-85.82%
TTM Avg
-222.53%
3Y Avg
-140.00%
5Y Avg
-73.12%
Market Cap
$12.17M
Return on Equity (ROE)
N/A
TTM Avg
-180.04%
3Y Avg
-6461.50%
5Y Avg
-4315.55%
Market Cap
$12.06M
Return on Equity (ROE)
-74.73%
TTM Avg
-265.78%
3Y Avg
-138.63%
5Y Avg
-109.18%
Market Cap
$13.11M
Return on Equity (ROE)
-810.41%
TTM Avg
-174.22%
3Y Avg
-126.94%
5Y Avg
-100.46%
Market Cap
$13.20M
Return on Equity (ROE)
-69.47%
TTM Avg
-55.64%
3Y Avg
-44.95%
5Y Avg
-41.56%
Market Cap
$11.93M
Return on Equity (ROE)
-106.87%
TTM Avg
-250.57%
3Y Avg
-230.96%
5Y Avg
-240.83%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempest Therapeutics, Inc. (TPST) | $12.58M | N/A | -404.74% | -329.53% | -239.41% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | N/A | -201.97% | -21.23% | 365.72% |
| Cytosorbents Corporation (CTSO)vs › | $12.44M | N/A | -162.71% | -135.96% | -98.83% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | -85.82% | -222.53% | -140.00% | -73.12% |
| Lantern Pharma Inc. (LTRN)vs › | $12.17M | N/A | -180.04% | -6461.50% | -4315.55% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.06M | -74.73% | -265.78% | -138.63% | -109.18% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | -810.41% | -174.22% | -126.94% | -100.46% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -69.47% | -55.64% | -44.95% | -41.56% |
| Biofrontera Inc. (BFRI)vs › | $11.93M | -106.87% | -250.57% | -230.96% | -240.83% |
| Optimi Health Corp. (OPTH)vs › | $13.30M | -39.76% | -59.76% | -51.18% | -40.48% |
ROE
N/A
ROA
-420.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -393.85% |
| 2025-09-30 | -568.14% |
| 2025-06-30 | -440.55% |
| 2025-03-31 | -402.40% |
| 2024-12-31 | -218.78% |
| 2024-09-30 | -310.01% |
| 2024-06-30 | -187.43% |
| 2024-03-31 | -144.24% |
| 2023-12-31 | -110.17% |
| 2023-06-30 | -663.75% |
| 2023-03-31 | -317.87% |
| 2022-12-31 | -197.17% |
| 2022-09-30 | -128.43% |
| 2022-06-30 | -96.04% |
| 2022-03-31 | -107.09% |
| 2021-12-31 | -78.36% |
| 2021-09-30 | -57.06% |
| 2021-06-30 | -46.07% |
| 2021-03-31 | -81.47% |
| 2020-09-30 | -70.47% |
| 2020-06-30 | -76.31% |
| 2020-03-31 | -71.39% |
| 2019-12-31 | -76.12% |
| 2019-09-30 | -88.94% |
| 2019-06-30 | -61.09% |
| 2019-03-31 | -49.07% |
| 2018-12-31 | -38.33% |
| 2018-09-30 | -65.20% |
| 2018-06-30 | -65.66% |
| 2018-03-31 | -75.79% |
| 2017-12-31 | -79.28% |
| 2017-09-30 | -90.04% |
| 2017-06-30 | -92.45% |
| 2017-03-31 | -79.60% |
| 2016-12-31 | -76.01% |
| 2016-09-30 | -61.76% |
| 2016-06-30 | -53.80% |
| 2016-03-31 | -71.45% |
| 2015-12-31 | -57.72% |
| 2015-09-30 | -50.15% |
| 2015-06-30 | -42.44% |
| 2015-03-31 | -34.84% |
| 2014-12-31 | -89.51% |
| 2014-09-30 | -60.66% |
| 2014-06-30 | -45.23% |
| 2014-03-31 | -36.69% |
| 2013-12-31 | -69.65% |
